Autor: |
A. Boeing, L. Mavrommatis, N.M. Daya, H. Zhuge, L. Volke, A. Kocabas, M. Kneifel, M. Athamneh, K. Krause, N. Südkamp, K. Döring, C. Theiss, A. Roos, H. Zaehres, A.K. Güttsches, M. Vorgerd |
Jazyk: |
angličtina |
Rok vydání: |
2023 |
Předmět: |
|
Zdroj: |
Stem Cell Research, Vol 72, Iss , Pp 103220- (2023) |
Druh dokumentu: |
article |
ISSN: |
1873-5061 |
DOI: |
10.1016/j.scr.2023.103220 |
Popis: |
Here we introduce the human induced pluripotent stem cell lines (hiPSCs), HIMRi002-A and HIMRi003-A, generated from cultured dermal fibroblasts of 61-year-old (HIMRi002-A) and 38-year-old (HIMRi003-A) female patients, carrying a known heterozygous pathogenic variant (p.A46T) in the Caveolin 3 (CAV3) gene, via lentiviral expression of OCT4, SOX2, KLF4 and c-MYC. HIMRi002-A and HIMRi003-A display typical embryonic stem cell-like morphology, carry the p.A46T CAV3 gene mutation, express several pluripotent stem cell markers, retain normal karyotype (46, XX) and can differentiate in all three germ layers. We postulate that the HIMRi002-A and HIMRi003-A iPSC lines can be used for the characterization of CAV3-associated pathomechanisms and for developing new therapeutic options. |
Databáze: |
Directory of Open Access Journals |
Externí odkaz: |
|